CN105901740A - Euphausia superba oil edible nutrient - Google Patents
Euphausia superba oil edible nutrient Download PDFInfo
- Publication number
- CN105901740A CN105901740A CN201610262896.XA CN201610262896A CN105901740A CN 105901740 A CN105901740 A CN 105901740A CN 201610262896 A CN201610262896 A CN 201610262896A CN 105901740 A CN105901740 A CN 105901740A
- Authority
- CN
- China
- Prior art keywords
- oil
- euphausia superba
- gram
- antarctic krill
- krill oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015097 nutrients Nutrition 0.000 title abstract description 4
- 241000239370 Euphausia superba Species 0.000 title abstract 5
- 239000007788 liquid Substances 0.000 claims abstract description 14
- 239000002775 capsule Substances 0.000 claims abstract description 6
- 229940106134 krill oil Drugs 0.000 claims description 21
- 239000007795 chemical reaction product Substances 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- 239000003921 oil Substances 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 4
- 210000005036 nerve Anatomy 0.000 abstract description 3
- 229910052785 arsenic Inorganic materials 0.000 abstract description 2
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 abstract description 2
- 230000004438 eyesight Effects 0.000 abstract description 2
- 229910001385 heavy metal Inorganic materials 0.000 abstract description 2
- 230000005855 radiation Effects 0.000 abstract description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract description 2
- 235000019198 oils Nutrition 0.000 abstract 5
- 239000012263 liquid product Substances 0.000 abstract 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 abstract 2
- 229960005375 lutein Drugs 0.000 abstract 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 abstract 2
- 235000012680 lutein Nutrition 0.000 abstract 2
- 239000001656 lutein Substances 0.000 abstract 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 abstract 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 abstract 2
- 235000005976 Citrus sinensis Nutrition 0.000 abstract 1
- 240000002319 Citrus sinensis Species 0.000 abstract 1
- 239000010502 orange oil Substances 0.000 abstract 1
- 241000239366 Euphausiacea Species 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000005471 carotenols Nutrition 0.000 description 1
- 150000001748 carotenols Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000038015 macular disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000021603 oncosis Effects 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses Euphausia superba oil edible nutrient, characterized by being made from the following materials according to weight: 300-500 g of Euphausia superba oil, 60-80 g of lutein, 40-50 g of MCT (medium chain triglyceride) and 80-100 g of sweet orange oil; the above materials are mixed well into a liquid product, and the liquid product is made into capsules or oral liquids. The fishy smell of Euphausia superba oil is solved, and this oil is easier to absorb and take; the added lutein and Euphausia superba oil are in perfect match, nourishing nerves, protecting eyesight and resisting radiation; the content of heavy metal, arsenic, in the nutrient is legal and qualified, completely meeting the national quality requirements.
Description
Technical field
The invention belongs to a kind of nutriment, be specially a kind of antarctic krill oil edible nutriment.
Background technology
Antarctic krill is the fourth-largest Renewable resource after grain, oil, coal, and its reserves are the most surprising, and high nutritive value, and protein content reaches more than 50 percent, is the biologies the highest containing protein that find so far of people.It is possibly together with aminoacid and vitamin A necessary to extremely abundant tissue.
Antarctic krill oil takes from pure wild Antarctic krill, and the mode utilizing ultralow temperature to extract is extracted, and is that the Nature is presented to the natural health food of the mankind, containing the irreplaceable effect of other food.Antarctic krill oil is the natural best nutritional food being uniquely made up of phospholipid, omega3, astaxanthin in nature, has powerful emulsification and abundant nutrient.Antarctic krill oil has superpower blood fat reducing, blood sugar lowering, hypotensive activity, blood brain barrier nutrition and activation brain cell and nerve can be passed through, play prevention and treatment cerebrovascular disease, coronary atherosclerosis, coronary heart disease etc., may also operate as anti-inflammation, prophylaxis of cancer develops, slow down aging, the multi-efficiency such as endocrine regulation.But, directly edible antarctic krill oil fishy smell is heavier, and mouthfeel is poor, and is not easy to absorb.
Summary of the invention
In order to solve the problems referred to above, the present invention provides a kind of antarctic krill oil edible nutriment, solves the fishy smell of antarctic krill oil, more easily absorbs and take.
The present invention is by the following technical solutions:
A kind of antarctic krill oil edible nutriment, it is characterised in that include the raw material of following weight: antarctic krill oil 300-500 gram, phylloxanthin 60-80 gram, MCT40-50 gram, oleum Citri sinensis 80-100 gram, above-mentioned raw materials mix homogeneously makes liquid end product.
Further, described liquid end product is made capsule or oral liquid.
Phylloxanthin is a kind of natural materials being widely present in the plants such as vegetable, flowers, fruit, belongs to " carotenoids class " race's material.Natural carotenol is a kind of excellent antioxidant, can resist free radical and cause cell and organ injury in human body, thus can prevent cardiovascula sclerosis, coronary heart disease and oncosis etc. that body aging causes.Phylloxanthin and cryptoxanthin are only 2 Carotenoids in eyes, prevent visual deterioration that senile eyeball retina macular disease causes with blind be the unique function of phylloxanthin.
MCT is median chain triglyceride oil, and it extracts from Oleum Cocois or Petiolus Trachycarpi oil, is widely used in preparation and the processing of numerous food.It is the mixture of saturated triglycerides, importantly octanoic acid (C8H16O2) and certain herbaceous plants with big flowers acid (C10H20O2), their content is not less than 95%.MCT has fabulous oxidation stability, cooling stability, low-viscosity, the most preferable dissolubility and lubricity.
Oleum Citri sinensis is a kind of by quintessence oil obtained by the employing cold-squeezing extraction of Fructus Citri junoris peel, and it is also the side-product of orange juice production process.Oleum Citri sinensis contributes to alleviating infection, and toxin is taken in, and the inside and outside inflammation that antibiotic etc side effect causes.It is natural spasmolytic medicine, is widely used in the discomfort that treatment spasm causes, as twitched, and persistent cough, muscle spasm and diarrhoea etc..Its benefit also includes facilitating digestion, and constipation relieving also increases vitamin C absorption.
The invention have the benefit that addition oleum Citri sinensis, phylloxanthin, MCT in Antarctic krill crude oil, this combination ensure that the robust stability of product to greatest extent, solves the fishy smell of antarctic krill oil, more easily absorbs and take；The phylloxanthin and the antarctic krill oil that add fit like a glove, and serve trophic nerve, protect vision, radiation-resistant effect；In the present invention, heavy metal arsenic content is legal qualified, complies fully with national quality requirement.
Detailed description of the invention
The present invention is further elaborated below:
A kind of antarctic krill oil edible nutriment, including the raw material of following weight: antarctic krill oil 300-500 gram, phylloxanthin 60-80 gram, MCT40-50 gram, oleum Citri sinensis 80-100 gram.Above-mentioned raw materials mix homogeneously is made liquid end product, liquid end product is made capsule or oral liquid.
Embodiment 1:
600 grams of these antarctic krill oil edible nutriments, including antarctic krill oil 400 grams, phylloxanthin 60 grams, MCT40 gram, oleum Citri sinensis 100 grams, make liquid end product by above-mentioned raw materials mix homogeneously, liquid end product are made the capsule of 0.5 gram.Be taken twice daily, one time one.
Embodiment 2:
600 grams of these antarctic krill oil edible nutriments, including antarctic krill oil 370 grams, phylloxanthin 80 grams, MCT50 gram, oleum Citri sinensis 100 grams, make liquid end product by above-mentioned raw materials mix homogeneously, liquid end product are made the capsule of 0.5 gram.Be taken twice daily, one time one.
Claims (2)
1. an antarctic krill oil edible nutriment, it is characterised in that include the raw material of following weight: antarctic krill oil 300-500 gram, phylloxanthin 60-80 gram, MCT40-50 gram, oleum Citri sinensis 80-100 gram, above-mentioned raw materials mix homogeneously makes liquid end product.
Antarctic krill oil edible nutriment the most according to claim 1, it is characterised in that described liquid end product is made capsule or oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610262896.XA CN105901740A (en) | 2016-04-26 | 2016-04-26 | Euphausia superba oil edible nutrient |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610262896.XA CN105901740A (en) | 2016-04-26 | 2016-04-26 | Euphausia superba oil edible nutrient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105901740A true CN105901740A (en) | 2016-08-31 |
Family
ID=56751956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610262896.XA Pending CN105901740A (en) | 2016-04-26 | 2016-04-26 | Euphausia superba oil edible nutrient |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105901740A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110074211A (en) * | 2019-06-05 | 2019-08-02 | 济南极源生物科技有限公司 | A kind of preparation method of the product containing antarctic krill oil and the product being prepared |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102860506A (en) * | 2012-08-08 | 2013-01-09 | 辽宁省大连海洋渔业集团公司 | Krill oil microcapsual powder and its preparation method |
| CN103608023A (en) * | 2011-06-15 | 2014-02-26 | 稳定解决方案有限责任公司 | Therapeutic application of parenteral krill oil |
| CN104489654A (en) * | 2014-12-02 | 2015-04-08 | 淄博十里香食品有限公司 | Process for producing walnut oil soft capsule |
-
2016
- 2016-04-26 CN CN201610262896.XA patent/CN105901740A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103608023A (en) * | 2011-06-15 | 2014-02-26 | 稳定解决方案有限责任公司 | Therapeutic application of parenteral krill oil |
| CN102860506A (en) * | 2012-08-08 | 2013-01-09 | 辽宁省大连海洋渔业集团公司 | Krill oil microcapsual powder and its preparation method |
| CN104489654A (en) * | 2014-12-02 | 2015-04-08 | 淄博十里香食品有限公司 | Process for producing walnut oil soft capsule |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110074211A (en) * | 2019-06-05 | 2019-08-02 | 济南极源生物科技有限公司 | A kind of preparation method of the product containing antarctic krill oil and the product being prepared |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103734712B (en) | Eye-protecting blueberry-raspberry functional food | |
| CN104605034A (en) | Nutrient plant blending oil and production method thereof | |
| CN103444911A (en) | Medicinal and edible health care blending oil | |
| CN102919383A (en) | Blend oil containing peony seed oil and preparation method of blend oil | |
| JP2008271878A (en) | Novel food and drink | |
| CN103230015A (en) | Extract compound for delaying senility, improving immunity and preventing and resisting cancer | |
| CN102907735A (en) | Processing technique and preparation of beverage capable of improving eyesight | |
| CN106689948B (en) | Collagen composite linolenic acid beverage and preparation method thereof | |
| CN105231287A (en) | Red bean walnut can | |
| CN107712537A (en) | A kind of lutein ester solid beverage | |
| CN101449824A (en) | Blueberry rose-hip bee pollen food | |
| CN106617049A (en) | Propolis healthcare product with moringa oleifera leaf extract and method for preparing propolis healthcare product | |
| RU2489038C1 (en) | Product for dietary, prophylactic and functional alimentation suitable for humans suffering from chronic cerebral ischemia | |
| CN105901740A (en) | Euphausia superba oil edible nutrient | |
| CN107197956A (en) | A kind of multi-function health-care edible oil | |
| CN101878914A (en) | Seabuckthorn compound oil combined health care products and preparation method thereof | |
| CN104473150A (en) | Method for producing tenebrio molitor-seabuckthorn flavored protein nutrient solution | |
| CN107173807A (en) | A kind of anti-oxidation health alimentation composition containing algae extract | |
| CN104286818A (en) | Zasiokaurin-containing salad sauce and preparation method thereof | |
| CN105105147A (en) | Nutrition and health care supplement rich in lutein and astaxanthin as well as preparation method | |
| CN105325563A (en) | Butterfat beef tallow paste and preparation method thereof | |
| CN108013316A (en) | A kind of Rosa roxburghii Tratt Fruit treasure and preparation method thereof | |
| EP3509430B1 (en) | Herbal beverage and method of its preparation | |
| CN105795274A (en) | Novel apple juice and preparation method thereof | |
| CN101451100A (en) | Blue berry purple wine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160831 |
|
| WD01 | Invention patent application deemed withdrawn after publication |